January 23, 2015 | By GUEST AUTHOR
Chemical industry financial analysts expect North American chemical companies to report solid fourth-quarter earnings, driven by lower raw material costs and solid demand, but the outlook for 2015 will be cautious. In research notes, the analysts cite a range of factors driving industry performance, but the recent collapse of crude oil pricing stands out. A majority of US chemical makers report are set to...
January 20, 2015 | By DEEPTI RAMESH
AMRI receives NIH contract for drug development and manufacturing services Albany Molecular Research Inc. (AMRI; Albany) says that it has received a 10-year federal contract award from the National Institutes of Health (NIH; Bethesda, MD) for drug development and manufacturing services. The NIH/National Institute of Neurological Disorders and Stroke (NINDS; Bethesda) award will support NIH's drug...
January 13, 2015 | By DEEPTI RAMESH
AMRI to acquire Aptuit’s drug product development and aseptic clinical manufacturing businesses Albany Molecular Research Inc. (AMRI; Albany, NY) says that it has acquired Aptuit’s (Greenwich, CT) Glasgow, UK, business and has entered into a definitive agreement to acquire Aptuit's SSCI (West Lafayette, IN) business for a total of $60.0 million, expanding AMRI's drug product development and...
January 6, 2015 | By DEEPTI RAMESH
FDA issues warning letter to API plant in China FDA issued a warning letter on 19 December to the active pharmaceutical ingredient (API) and finished pharmaceutical manufacturing facilities of Novacyl Wuxi Pharmaceutical —located at Wuxi, China—for violations of cGMP. The warning letter was published on the FDA Web site on 30 December. An FDA inspection from 13–18 October 2013 at the Wuxi...
December 30, 2014 | By DEEPTI RAMESH
Merck KGaA receives US antitrust clearance for acquisition of Sigma-Aldrich for $17 billion Merck KGaA (Darmstadt, Germany) and life science company Sigma-Aldrich (St. Louis) announced that Merck has obtained antitrust clearance from the US FTC for its previously announced planned acquisition of Sigma-Aldrich. Merck announced in September that it has agreed to acquire Sigma-Aldrich for $17.0 billion...
December 23, 2014 | By DEEPTI RAMESH
Cambridge Major to expand Germantown API facility Cambridge Major Laboratories (CML; Germantown, WI), a producer of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), is investing more than $20 million in its R&D and manufacturing facilities at Germantown, the Wisconsin Economic Development Corp. (WEDC; Madison, WI) says. WEDC leads economic development efforts for the state by...
December 12, 2014 | By LINDSAY FROST
This Week in CW: US chemical output is set accelerate sharply through the end of the decade, exceeding the growth of the overall US economy, according to ACC’s Year End 2014 Chemical Industry Situation and Outlook, published this week. ACC forecasts a 3.7% US chemical output gain in 2015, up from 2% in 2014, and an even stronger gain of 3.9% for 2016. The forecast puts the US chemical industry on...
December 9, 2014 | By DEEPTI RAMESH
Johnson Matthey acquires pharmaceutical ingredients facility in UK Johnson Matthey says that it has completed the acquisition of a pharmaceutical manufacturing facility at Annan, UK. The site, which was originally constructed by Glaxo in 1980, changed hands several times and was most recently owned by Bakhu Pharma (Bromborough, UK). A multimillion-pound refurbishment will start in early 2015 to update and...
December 5, 2014 | By LINDSAY FROST
This Week in CW: Vertellus (Indianapolis), a leading producer of specialty chemicals for the life sciences sector and other industrial applications, has signed a definitive agreement to acquire the sodium borohydride business, including associated assets, from the Dow Chemical, Vertellus announced today. The company is a portfolio company of private equity firm Wind Point Partners (Chicago). Wind Point...
December 2, 2014 | By DEEPTI RAMESH
Siegfried acquires German pharma firm Siegfried (Zofingen, Switzerland), a producer of active pharmaceutical ingredients (APIs), pharma intermediates, and finished drugs, says that it has acquired Hameln Pharma (Hameln, Germany) from the privately held Hameln Group, for 60 million Swiss francs ($62 million). Hameln Pharma is active in the development and production of sterile liquid pharmaceutical...
ABOUT CHEM IDEAS
Welcome to Chem Ideas, the place for opinions and perspective on the key issues affecting the global chemicals industry. This zone features articles by Chemweek’s regular editors as well as a team of established experts with insights across the chemicals industry. If you would like to contribute a blog or opinion piece contact Lindsay.Frost@ihs.com.
CLICK HERE TO LEARN ABOUT CHEMWEEK'S EDITORS
ABOUT OUR GUEST AUTHORS
Fine Chemicals / Pharma
Girish Malhotra is the president and founder of Epcot International, an international consulting firm covering chemical manufacture. Girish is an established industry figure having held senior positions at companies including ExxonMobil and Sherwin Williams. He can be reached at email@example.com
Lawrence D. Sloan became Socma's
President in early 2010. He says he will continue to drive up the interests of his members on issues including regulation and best business practice.
Lisa Allen is the Technical Manager of ReachReady, the Reach services body affiliated to the Chemical Industries Assocation (CIA; U.K.).
She spends much of her time addressing concerns raised by ReachReady’s customers about Reach.
Kathryn Sheridan is the founder of Sustainability Consult, providing public relations support with a sustainability focus to a number of chemical industry clients, as well as to other sectors. Sustainability Consult helps organisations develop, promote and communicate their sustainability strategies, plans and activities. firstname.lastname@example.org
Rubber and Plastics
Lou Reade is a freelance journalist and expert in the rubber and plastics fields. Based in the U.K. Lou has more than a decade writing in about rubber and plastics manufacture with a wealth of experience gained while writing for the leading publications in the field in the U.K. and wider afield. Loureade@talk21.com.
Giles Chappell is an attorney based in Geneva. His practice focuses on chemicals—specifically REACH and the CLP Regulation, product safety legislation, environmental and trade compliance, and market access issues. He was recommended in 2012 by the Chambers & Partners legal directory. email@example.com
Steve Roberts is an attorney who practices in the rapidly developing area of homeland security law and regulation. Steve writes and speaks frequently on the legal aspects of homeland security and counterterrorism affecting the nation’s critical infrastructure. www.chemicalsecurity.com